ArticleEnvironmental challenges (Amsterdam, Netherlands)2021
COVID-19 second wave: District level study of concentration of confirmed cases and fatality in India.
Article in Environmental challenges (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 23 citations in OpenAlex.
- Lived Experience is Our Superpower: Narratives from Four Global Shapers, World Economic Forum (WEF) Youth Mental Health Leaders Journeys.PLOS mental health · 2025Article
- Article
- Association of greenness with COVID-19 deaths in India: An ecological study at district level.Environmental research · 2023Article
- The continued effects of COVID-19 on the lives and livelihoods of vegetable farmers in India.PloS one · 2023Article
- Spatial variation of covid-19 morbidity status and identification of risk zone in Tamil Nadu (India) during first wave.GeoJournal · 2023Article
- COVID-19 positive cases among asymptomatic individuals during the second wave in Ndola, Zambia.African journal of laboratory medicine · 2023Article
- Household secondary attack rate in SARS-CoV-2 infection during the second wave of the COVID-19 pandemic in South India.Journal of family medicine and primary care · 2022Article
- Article
- Fragility and challenges of health systems in pandemic: lessons from India's second wave of coronavirus disease 2019 (COVID-19).Global health journal (Amsterdam, Netherlands) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The paper aims to reveal the spatial pattern of the concentration of COVID-19 confirmed cases and the spread of the pandemic from the Case Fatality Ratio. The study has been accomplished with district-level data. The analysis of the spatial pattern decoding has been done considering the Global and Local Moran's I statistics comprising the linear trend of spatial autocorrelation for the whole India. The timeframe has been divided considering the surge of the second wave in March, 2021 and the peak of the wave in May 2021. The spatial clustering technique presents both the concentration of confirmed cases using Location Quotient analysis and the pattern of spread of the infection-related fatality throughout the country. The high Location Quotient of the confirmed cases strongly clustered around the Mumbai-Puna region, Kerala-Karnataka region, Garhwal Himachal, NCT of Delhi and Ladakh-Kashmir-Himachal Pradesh region during the period of the study. In May, the concentration has randomly clustered around the middle part of India. The Case Fatality Ratio was high in Maharashtra, Madhya Pradesh, Punjab and Haryana at the surge of the second wave. During the peak (May), two significant clusters of high Case Fatality Ratio are observed in and around the Mumbai urban (Maharashtra) and NCT of Delhi (including Punjab-Haryana).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.